Dear Editor,
COVID-19 is an important emerging respiratory infection. This novel coronavirus infection can causes lung problem and might result in death. The patients with underlying disease might have poor clinical course.[1] There are many possible concurrent medical disorders with COVID-19. Epilepsy is a common neurological disorder. There is no report on epilepsy and COVID-19. Here, the authors would like to share observations from Thailand, the second country in the timeline of COVID-19 worldwide outbreak.[2]
At present (3th March 2020), there are 1,978 patients with COVID-19 in Thailand (there are 19 death cases). Epilepsy is comorbidity in one patient (0.05%). The patient had mild infection, and there is no seizure presentation at initial illness or during hospitalization for antiviral treatment. The patient had complete recovery. This is the first preliminary data on coincidence between epilepsy and COVID-19. Further studies are required for assessment clinical association between epilepsy and cOVID-19.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
- 1.Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19:A systematic review and meta-analysis. Arch Acad Emerg Med. 2020;8:e35. [PMC free article] [PubMed] [Google Scholar]
- 2.Yasri S, Wiwanitkit V. Editorial:Wuhan coronavirus outbreak and imported case. Adv Trop Med Pub Health Int. 2019;9:1–2. [Google Scholar]